VF
TLSI icon

Virtu Financial’s TriSalus Life Sciences TLSI Stock Holding History

Virtu Financial’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,875
Closed -$92K – 2052
2024
Q3 		$92K Buy
+19,875
New +$105K 0.01% 928
2023
Q2 		– Sell
-10,347
Closed -$106K – 2039
2023
Q1 		$106K Sell
10,347
-1,973
-16% -$20K 0.01% 964
2022
Q4 		$124K Buy
+12,320
New +$124K 0.02% 880
2022
Q2 		– Sell
-21,482
Closed -$211K – 2069
2022
Q1 		$211K Buy
+21,482
New +$212K 0.02% 755

Other funds holding TLSI

WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial's TLSI Position: Q4 2024 in Review

Virtu Financial sold out of TriSalus Life Sciences (TLSI) in Q4 2024, closing a stake of 19,875 shares — an estimated $92K sold.

Virtu Financial first reported a position in TLSI in Q1 2022 and held it in 4 quarters. The position peaked at $211K in Q1 2022. 30 funds tracked by Wall St. Rank hold TLSI as of Q4 2024.

  • Virtu Financial reported no remaining TriSalus Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 19,875 TriSalus Life Sciences shares in Q4 2024, an estimated $92K.
  • Virtu Financial first reported a position in TriSalus Life Sciences in Q1 2022 and held it in 4 quarters.
  • Virtu Financial's TriSalus Life Sciences position peaked at $211K in Q1 2022.
  • 30 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.